Hemogenyx Pharmaceuticals' Biz Plan Competition Round

Hemogenyx Pharmaceuticals raised a round of funding on October 30, 2014. Investors include 43North.

HemoGenyx is developing a new type of treatment for leukemia, lymphoma, and other blood disorders using a special class of cells harvested from a patient's liver that make bone marrow transplants more…

Articles about Hemogenyx Pharmaceuticals' Biz Plan Competition Round: